Get the Stockscreener App
4.16
2.12%
-0.09
After Hours:
4.10
-0.06
-1.44%
Achieve Life Sciences Inc Stock (ACHV) Forecast
The Achieve Life Sciences Inc (ACHV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $52.30, representing a +1,157% increase from the current price of $4.16. The highest analyst price target is $51.80, and the lowest is $52.80.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACHV Price Target
Average 54.47
(+1,209% Upside)
Is Achieve Life Sciences Inc (ACHV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.64 | Neutral |
| STOCH(9,6) | 15.05 | Buy |
| STOCHRSI(14) | 13.80 | Buy |
| MACD(12,26) | -0.1242 | Sell |
| ADX(14) | 18.55 | Neutral |
| William %R | -96.64 | Buy |
| CCI(14) | -175.61 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.605
Sell
|
4.4996
Sell
|
| MA20 |
4.6775
Sell
|
4.629
Sell
|
| MA50 |
4.7189
Sell
|
4.6922
Sell
|
| MA100 |
4.6601
Sell
|
4.6918
Sell
|
| MA200 |
4.6605
Sell
|
4.6909
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ACHV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ACHV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.64 indicates that ACHV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.05 indicates that ACHV is oversold. This indicates that ACHV price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.8 indicates that ACHV is oversold. This suggests that ACHV price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.55 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -175.61 indicates that ACHV is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ACHV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Achieve Life Sciences Inc financial reports and earnings history, Achieve Life Sciences Inc (ACHV) stock could reach $76.95 by 2030, $54.74 by 2040 and $179.11 by 2050. See the projected annual prices until 2050 of the Achieve Life Sciences Inc stock below:
- Achieve Life Sciences Inc (ACHV) is expected to reach an average price of $17.24 in 2035, with a high prediction of $20.68 and a low estimate of $17.61. This indicates an $314.48% rise from the last recorded price of $4.16.
- Achieve Life Sciences Inc (ACHV) stock is projected to chart a bullish course in 2040, with an average price target of $51.44, representing an $1,136% surge from its current level. The forecast ranges from a conservative $52.06 to a sky-high $54.74.
- Our analysts predict Achieve Life Sciences Inc (ACHV) to jump 2,537% by 2045, soaring from $109.75 to an average price of $109.70, potentially reaching $111.21. While $109.75 is the low estimate, the potential upside is significant.
- Achieve Life Sciences Inc (ACHV) stock is expected to climb by 2050, reaching an average of $175.54, a $4,120% jump from its current level. However, a wide range of estimates exists, with high and low targets of $179.11 and $176.86, respectively, highlighting the market's uncertainty.
Achieve Life Sciences Inc Stock (ACHV) Year by Year Forecast
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2024
Our forecast for ACHV stock price in 2024 now indicates an average price target of $26.04 with a high forecast of $51.80 and a low forecast of $0.2792. The average prediction reflects an increase of +525.93% from the last recorded price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $51.85 | $52.80 | $51.80 | +1,147% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2025
Achieve Life Sciences Inc Stock (ACHV) is expected to reach an average price of $53.90 in 2025, with a high prediction of $59.14 and a low estimate of $48.67. This indicates an +1,196% rise from the last recorded price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $57.89 | $56.70 | $58.19 | +1,292% |
| February, 2025 | $56.62 | $56.88 | $56.04 | +1,261% |
| March, 2025 | $57.33 | $56.57 | $56.47 | +1,278% |
| April, 2025 | $59.41 | $57.60 | $59.14 | +1,328% |
| May, 2025 | $57.31 | $57.60 | $58.61 | +1,278% |
| June, 2025 | $56.29 | $55.84 | $55.35 | +1,253% |
| July, 2025 | $53.93 | $54.33 | $54.48 | +1,196% |
| August, 2025 | $53.36 | $53.48 | $53.58 | +1,183% |
| September, 2025 | $49.33 | $49.80 | $52.27 | +1,086% |
| October, 2025 | $51.69 | $51.38 | $50.97 | +1,142% |
| November, 2025 | $49.67 | $49.83 | $50.39 | +1,094% |
| December, 2025 | $48.91 | $48.67 | $49.03 | +1,076% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2026
The predicted value for Achieve Life Sciences Inc (ACHV) in 2026 is set at an average of $41.48. Estimates vary from a peak of $47.69 to a trough of $35.28, indicating an +897.23% surge from the present price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $46.66 | $46.98 | $47.69 | +1,022% |
| February, 2026 | $47.29 | $47.11 | $47.12 | +1,037% |
| March, 2026 | $43.99 | $45.15 | $46.25 | +957.56% |
| April, 2026 | $38.36 | $39.07 | $39.70 | +822.18% |
| May, 2026 | $39.18 | $40.12 | $39.74 | +841.90% |
| June, 2026 | $39.06 | $39.37 | $39.16 | +839.02% |
| July, 2026 | $39.79 | $38.93 | $38.91 | +856.52% |
| August, 2026 | $39.48 | $39.75 | $39.47 | +849.08% |
| September, 2026 | $38.84 | $38.57 | $39.08 | +833.65% |
| October, 2026 | $38.68 | $38.88 | $38.31 | +829.81% |
| November, 2026 | $36.56 | $37.12 | $38.08 | +778.86% |
| December, 2026 | $35.15 | $35.28 | $36.09 | +744.92% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Achieve Life Sciences Inc (ACHV) is $30.14, with a high forecast of $34.54 and a low forecast of $25.74. This indicates an +624.52% increase from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $34.39 | $34.89 | $34.54 | +726.66% |
| February, 2027 | $33.99 | $33.92 | $33.99 | +717.05% |
| March, 2027 | $33.05 | $33.77 | $33.54 | +694.41% |
| April, 2027 | $30.99 | $31.75 | $32.02 | +644.90% |
| May, 2027 | $30.78 | $31.20 | $31.21 | +639.86% |
| June, 2027 | $30.38 | $30.10 | $30.18 | +630.19% |
| July, 2027 | $28.51 | $28.94 | $29.64 | +585.25% |
| August, 2027 | $27.43 | $27.63 | $28.18 | +559.30% |
| September, 2027 | $26.81 | $27.38 | $27.02 | +544.59% |
| October, 2027 | $27.19 | $26.52 | $26.55 | +553.49% |
| November, 2027 | $26.59 | $26.98 | $27.04 | +539.08% |
| December, 2027 | $25.52 | $25.74 | $26.08 | +513.55% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2028
In 2028, Achieve Life Sciences Inc (ACHV) is projected to reach an average price of $18.19, with a high projection of $25.11 and a low estimate of $11.27. This indicates an +337.22% rise from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $24.92 | $25.15 | $25.11 | +499.14% |
| February, 2028 | $25.20 | $24.65 | $24.60 | +505.88% |
| March, 2028 | $25.03 | $24.99 | $24.94 | +501.74% |
| April, 2028 | $23.32 | $23.90 | $24.67 | +460.64% |
| May, 2028 | $22.47 | $22.61 | $23.02 | +440.16% |
| June, 2028 | $19.40 | $19.89 | $22.12 | +366.37% |
| July, 2028 | $17.59 | $17.94 | $18.51 | +322.87% |
| August, 2028 | $17.25 | $17.27 | $17.14 | +314.65% |
| September, 2028 | $13.62 | $14.10 | $16.74 | +227.40% |
| October, 2028 | $10.96 | $11.46 | $12.93 | +163.47% |
| November, 2028 | $11.67 | $11.27 | $12.23 | +180.49% |
| December, 2028 | $12.21 | $11.93 | $11.50 | +193.48% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2029
The 2029 price forecast for Achieve Life Sciences Inc Stock (ACHV) is $34.53 on average, with a high prediction of $68.96 and a low estimate of $0.0963. This represents an +730.00% increase from the previous price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.54 | $10.66 | $11.89 | +153.29% |
| February, 2029 | $10.49 | $10.39 | $10.18 | +152.09% |
| March, 2029 | $9.4775 | $9.5875 | $9.8447 | +127.83% |
| April, 2029 | $9.3879 | $9.411 | $9.1675 | +125.67% |
| May, 2029 | $7.7359 | $7.9459 | $8.7555 | +85.96% |
| June, 2029 | $4.9963 | $5.0863 | $6.2935 | +20.10% |
| July, 2029 | $5.7067 | $5.2739 | $6.3891 | +37.18% |
| August, 2029 | $3.6347 | $3.6847 | $5.3143 | -12.63% |
| September, 2029 | $3.5951 | $3.5075 | $3.2759 | -13.58% |
| October, 2029 | $1.6931 | $1.8031 | $2.7628 | -59.30% |
| November, 2029 | $0.7735 | $1.0835 | $1.2267 | -81.41% |
| December, 2029 | $73.96 | $0.0963 | $68.96 | +1,678% |
Achieve Life Sciences Inc Stock (ACHV) Price Forecast for 2030
Achieve Life Sciences Inc Stock (ACHV) is expected to reach an average price of $102.52 in 2030, with a high forecast of $127.59 and a low forecast of $77.44. This signifies an +2,364% surge from the last price of $4.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $104.44 | $77.44 | $76.95 | +2,411% |
| February, 2030 | $117.02 | $108.53 | $111.82 | +2,713% |
| March, 2030 | $114.40 | $114.90 | $113.60 | +2,650% |
| April, 2030 | $108.58 | $111.78 | $110.89 | +2,510% |
| May, 2030 | $111.45 | $104.86 | $107.85 | +2,579% |
| June, 2030 | $114.08 | $114.44 | $113.44 | +2,642% |
| July, 2030 | $123.91 | $117.03 | $122.71 | +2,879% |
| August, 2030 | $129.59 | $123.21 | $120.21 | +3,015% |
| September, 2030 | $125.16 | $127.07 | $127.59 | +2,909% |
| October, 2030 | $124.02 | $124.19 | $123.85 | +2,881% |
| November, 2030 | $126.59 | $124.21 | $123.45 | +2,943% |
| December, 2030 | $124.54 | $124.71 | $125.23 | +2,894% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):